Abstract YO29
Case summary
A 72-year-old Japanese man presented with symptoms of chest pain and poor appetite. Contrast-enhanced CT scan showed a solid mass (diameter:80mm) with slight enhancement located in the left inferior posterior mediastinum. The mass surrounded the descending aorta at the T8-T10 level, partly infiltrating the aorta. Primary mediastinal undifferentiated sarcoma was diagnosed by CT-guided percutaneous needle biopsy. No distant metastasis was apparent on whole diffusion MRI. He was scheduled to undergo chemo radiotherapy, but 3weeks after the diagnosis, sudden anuria was observed, and his blood test revealed acute kidney injury and hyperkalemia. Contrast-enhanced CT-scan revealed occlusion of bilateral renal artery at its origin, and hemodialysis was immediately performed. We suspected that occlusion was caused by tumor embolism. The patient received catheter-directed thrombolysis to improve his renal function and to confirm diagnosis. Tumor cells identifiable as primary lesion were pathologically recognized from a part of the embolus collected by the catheter, which proves acute kidney injury secondary to bilateral renal artery tumor thrombosis. After the treatment, the renal dysfunction remarkably improved and he was able to be taken off dialysis.
Intravascular tumor thrombus often occurs in the venous system. However, we present a rare case of undifferentiated sarcoma patient with mediastinal origin that developed acute kidney injury due to bilateral renal artery tumor thrombosis and successfully treated with catheter-directed thrombolysis.
Clinical trial identification
Editorial acknowledgement
Resources from the same session
518P - Real world prospective clinical impact of finding actionable genomic alterations by plasma cell-free DNA next generation sequencing in advanced non-small cell lung cancer
Presenter: Beung chul Ahn
Session: Poster display session
Resources:
Abstract
508P - Efficacy and safety of anti-PD-1 antibody SHR-1210 combined with apatinib in first-line treatment for advanced lung squamous carcinoma: A phase II study
Presenter: Jinliang Wang
Session: Poster display session
Resources:
Abstract
525P - Retrospective analysis of outcomes of cisplatin and irinotecan combination chemotherapy for unresectable thymic carcinoma
Presenter: Akito Fukuda
Session: Poster display session
Resources:
Abstract
524P - A study in recurrent small cell lung cancer patients, comparing weekly paclitaxel, irinotecan and temozolomide in second-line: A prospective study from a south Indian tertiary cancer hospital
Presenter: LALATENDU MOHARANA
Session: Poster display session
Resources:
Abstract
505P - PD-L1 expression in ALK rearranged NSCLC: All questions answered?
Presenter: Amrith B P
Session: Poster display session
Resources:
Abstract
487P - Afatinib versus gefitinib or erlotinib in first-line setting for Malaysia patients with EGFR mutant advanced lung adenocarcinoma
Presenter: Chee Shee Chai
Session: Poster display session
Resources:
Abstract
492P - Feasibility of rebiopsy and sequential treatment of EGFR tyrosine kinase inhibitors in real world patients with EGFR mutant non-small cell lung cancer
Presenter: Heekyung Ahn
Session: Poster display session
Resources:
Abstract
513P - Phase II study of vitamin B12 and folate supplementation for patients undergoing chemotherapy with pemetrexed
Presenter: Shingo Kitagawa
Session: Poster display session
Resources:
Abstract
493P - Is exon 19 deletion different from exon 21 mutation in advanced non-small cell lung cancer: A single centre experience
Presenter: Sarita Shrivastva
Session: Poster display session
Resources:
Abstract
494P - Comparison of pattern of disease progression and prevalence of acquired T790M mutation in Malaysia patients with EGFR mutant lung adenocarcinoma upon failure of first-line afatinib, gefitinib and erlotinib
Presenter: Chee Shee Chai
Session: Poster display session
Resources:
Abstract